Enteric fever: A travel medicine oriented view

Current Opinion in Infectious Diseases

Volumn 23, Issue 5, 2010, Pages 432-437

  Meltzer, Eyal ^a,b   Schwartz, Eli ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Salmonella Paratyphi; Salmonella Typhi; typhoid fever

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; GATIFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TYPHOID VACCINE;

ANTIBIOTIC RESISTANCE; HUMAN; INDIA; INFECTION PREVENTION; REVIEW; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SOUTHEAST ASIA; TRAVEL; TYPHOID FEVER; VACCINATION;

ANTI-BACTERIAL AGENTS; ASIA, SOUTHEASTERN; DRUG RESISTANCE, BACTERIAL; HUMANS; INCIDENCE; INDIA; PARATYPHOID FEVER; SALMONELLA PARATYPHI A; SALMONELLA TYPHI; SALMONELLA VACCINES; TRAVEL MEDICINE; TYPHOID FEVER; VACCINATION;

EID: 77956229249     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32833c7ca1     Document Type: Review

References (39)

1. Pegues DA, Miller SI. Salmonella species including Salmonella typhi [Chap 223]. In: Mandell GL Bennett JE Dolin R editors. Principles practice of infectious diseases. 7th ed.; Elsevier 2010.
2. European Commission Health and Consumers Directorate-Gen eral. Typhoid and paratyphoid fever data 1997-2006 downloaded from http://ec. europa.eu/health/ph-information/dissemination/echi/docs/typhoid-en.pdf on 04.05.10.
3. RizzoC, Santantonio M, CosciaMF, etal. Typhoid fever in Italy, 2000-2006. J Infect Dev Ctries 2008; 2:466-468.
4. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ 2004; 82:346-353.
5. Caribbean Epidemiology Centre (CAREC/PAHO/WHO) typhoid data. http://www.carec.net/pdf/mobidityreview/30.%20Typhoid.pdf on 04.05.10.
6. Laval E, Ferreccio C. Typhoid fever: rise, peak and fall of an infectious disease in Chile. Rev Chilena Infectol 2007; 24:435-440.
7. Ghenghesh KS, Franka E, Tawil K, etal. Enteric fever in Mediterranean North Africa. J Infect Dev Ctries 2009; 3:753-761.
8. Ochiai RL, AcostaCJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 2008; 86:260-268.
9. Kanungo S, Dutta S, Sur D. Epidemiology of typhoid and paratyphoid fever in India. J Infect Dev Ctries 2008; 2:454-460.
10. Wu W, Wang H, Lu J, et al. Genetic diversity of Salmonella enteric serovar Typhi and Paratyphiin Shenzhen, China from 2002 through 2007. BMC Microbiol 2010; 10:32.
11. Meltzer E, Sadik C, Schwartz E. Enteric fever in Israeli travelers: a nationwide study. J Travel Med 2005; 12:275-281.
12. Galanis E, Lo Fo Wong DM, Patrick ME, et al. Web-based surveillance and global Salmonella distribution, 2000-2002. Emerg Infect Dis 2006; 12:381-388.
13. Gupta SK, Medalla F, Omondi MW, et al. Laboratory-based surveillance of paratyphoid fever in the United States: travel and antimicrobial resistance. Clin Infect Dis 2008; 46:1656-1663.
14. Erdem B, Ercis S, Hascelik G, et al. Antimicrobial resistance patterns and serotype distribution among Salmonella enterica strains in Turkey, 2000-2002. Eur J Clin Microbiol Infect Dis 2005; 24:220-225.
15. Mermin JH, Townes JM, Gerber M, et al. Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998; 158:633-638.
16. United Kingdom Health Protection Agency. Salmonella Typhi and Salmonella Paratyphi Laboratory report (cases only). http://www.hpa.org.uk/web/HPA webFile/HPAweb-C/1206575041711 on 04/05/10.
17. Ekdahl K, De Jong B, Andersson Y. Risk of travel-associated typhoid and paratyphoid fevers in various regions. J Travel Med 2005; 12:197-204.
18. Lynch MF, Blanton EM, Bulens S, et al. Typhoid fever in the United States, 1999-2006. JAMA 2009; 302:859-865.
19. Keller A, Frey M, Schmid H, et al. Imported typhoid fever in Switzerland, 1993 to 2004. J Travel Med 2008; 15:248-251.
20. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354:119-130.
21. Wain J, Pham VB, Ha V, et al. Quantitation of bacteria in bone marrow from patients with typhoid fever: relationship between counts and clinical features. J Clin Microbiol 2001; 39:1571-1576.
22. Olsen SJ, Pruckler J, Bibb W, et al. Evaluation of rapid diagnostic tests for typhoid fever. J Clin Microbiol 2004; 42:1885-1889.
23. Wain J, Hosoglu S. The laboratory diagnosis of enteric fever. J Infect Dev Ctries 2008; 2:421-425.
24. HattaM,SmitsHL. Detection of Salmonella Typhi by nested polymerase chain reaction in blood, urine, and stool samples. Am J Trop Med Hyg 2007; 76:139-143.
25. Ali A, Haque A, Haque A, et al. Multiplex PCR for differential diagnosis of emerging typhoidal pathogens directly from blood samples. Epidemiol Infect 2009; 137:102-107.
26. Crump JA, Kretsinger K, Gay K, et al. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased suscept ibility to fluoroquinolones: a United States FoodNet Multicenter Retrospective Cohort study. Antimicrob Agents Chemother 2008; 52:1278-1284.
27. Bhutta ZA. Therapeutic aspects of typhoidal salmonellosis in childhood: the Karachi experience. Ann Trop Paediatr 1996; 16:299-306.
28. FrenckRW Jr, Nakhla I, Sultan Y, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis 2000; 31:1134-1138.
29. Dolecek C, Tran TP, Nguyen NR, et al. A multicenter randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One 2008; 3:e21 88.
30. Mintz E. Typhoid and paratyphoid fever. Chapter 2. The pre-travel consultation, travel-related vaccine-preventable diseases. The Centers for Disease Control and Prevention Yellow Book 2010. http://wwwnc.cdc.gov/travel/ yellowbook/2010/chapter-2/typhoid-paratyphoid-fever.aspx on 04.04.2010.
31. WHO. Chapter 6. Vaccine-preventable diseases and vaccines. International Travel and Health 2010. http://www.who.int/ith/ITH2010chapter6.pdf on 04.04.2010.
32. Schwartz E, Shlim DR, Eaton M, et al. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella Typhi and Salmonella Paratyphi A among foreigners in Nepal. Arch Intern Med 1990; 150:349-351.
33. Jin Y. Enteric fever in south China: Guangxi province. J Infect Dev Ctries 2008;2:283-288.
34. Fraser A, Paul M, Goldberg E, et al. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine 2007; 25:7848-7857.
35. Sur D, Ochiai RL, Bhattacharya SK, et al. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med 2009; 361:335-344.
36. Lin FY, Ho VA, Khiem HB, et al. The efficacy of a Salmonella Typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 2001; 344:1263-1269.
37. Mai NL, Phan VB, Vo AH, et al. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. N Engl J Med 2003; 349:1390-1391.
38. Levine MM, Ferreccio C, Black RE, et al. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica serovar Paratyphi B. Clin Infect Dis 2007; 45 (Suppl 1):S24-S28.
39. Roland KL, Tinge SA, Kochi SK, et al. Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates. Vaccine 2010; 28:3679-3687.